Ability of procalcitonin to diagnose bacterial infection and bacteria types compared with blood culture findings
- PMID: 27757046
- PMCID: PMC5053384
- DOI: 10.2147/IJGM.S115277
Ability of procalcitonin to diagnose bacterial infection and bacteria types compared with blood culture findings
Abstract
Procalcitonin (PCT) and C-reactive protein serve as biomarkers of infection in patients with sepsis/bacteremia. The present study assessed the clinical characteristics of 280 patients with suspected sepsis who were admitted to Tohoku Medical and Pharmaceutical University Hospital between January 2012 and December 2013. Among the patients, 133 and 147 were positive and negative for PCT, respectively. Patients who were PCT positive were older and more frequently male, had reduced levels of platelets and albumin, and increased levels of aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, creatinine, and C-reactive protein. Patients who were PCT positive had significantly higher blood culture positivity compared with those who were PCT negative, and the sensitivity and specificity of PCT for detecting positive blood cultures were 74.5% and 59.1%, respectively. Escherichia coli was detected in PCT-positive patients, whereas Staphylococcus epidermidis and Staphylococcus lugdunensis were frequently detected in PCT-negative patients. Levels of PCT were higher in the patients infected with gram-negative rods than those with gram-positive cocci. Furthermore, extended-spectrum β-lactamase (ESBL)-producing bacteria cases showed higher levels of PCT than those of non-ESBL cases. These results suggest that PCT may be a useful biomarker of sepsis, and it might serve as a strong tool to detect patients with severe gram-negative rod bacteremia including ESBL-producing bacteria cases early due to its relative high sensitivity.
Keywords: ESBL; Escherichia coli; biomarker; gram-negative rods; sepsis.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures


Similar articles
-
Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria.Am J Emerg Med. 2017 Apr;35(4):579-583. doi: 10.1016/j.ajem.2016.12.017. Epub 2016 Dec 10. Am J Emerg Med. 2017. PMID: 27979420
-
Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria.Ir J Med Sci. 2017 Feb;186(1):207-212. doi: 10.1007/s11845-016-1457-z. Epub 2016 May 2. Ir J Med Sci. 2017. PMID: 27139197
-
Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis.J Res Med Sci. 2016 Jun 14;21:39. doi: 10.4103/1735-1995.183996. eCollection 2016. J Res Med Sci. 2016. PMID: 27904585 Free PMC article.
-
Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.Clin Infect Dis. 2019 Jul 18;69(3):388-396. doi: 10.1093/cid/ciy917. Clin Infect Dis. 2019. PMID: 30358811
-
The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?Surg Infect (Larchmt). 2013 Dec;14(6):489-511. doi: 10.1089/sur.2012.028. Epub 2013 Nov 25. Surg Infect (Larchmt). 2013. PMID: 24274059 Review.
Cited by
-
The effect of malaria rapid diagnostic tests results on antimicrobial prescription practices of health care workers in Burkina Faso.Ann Clin Microbiol Antimicrob. 2019 Jan 28;18(1):5. doi: 10.1186/s12941-019-0304-2. Ann Clin Microbiol Antimicrob. 2019. PMID: 30691506 Free PMC article.
-
Procalcitonin as a biomarker of bacterial infection in critically ill patients admitted with suspected Sepsis in Intensive Care Unit of a tertiary care hospital.Pak J Med Sci. 2021 Nov-Dec;37(7):1999-2003. doi: 10.12669/pjms.37.7.4183. Pak J Med Sci. 2021. PMID: 34912433 Free PMC article.
-
Challenges of Antibiotic Stewardship in the Pediatric and Neonatal Intensive Care Units.J Pediatr Pharmacol Ther. 2021;26(7):659-668. doi: 10.5863/1551-6776-26.7.659. Epub 2021 Sep 24. J Pediatr Pharmacol Ther. 2021. PMID: 34588929 Free PMC article.
-
A Novel Combination of Biomarkers to Herald the Onset of Sepsis Prior to the Manifestation of Symptoms.Shock. 2018 Apr;49(4):364-370. doi: 10.1097/SHK.0000000000001010. Shock. 2018. PMID: 29016484 Free PMC article. Review.
-
The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics.PLoS One. 2018 Nov 14;13(11):e0206527. doi: 10.1371/journal.pone.0206527. eCollection 2018. PLoS One. 2018. PMID: 30427887 Free PMC article.
References
-
- Nishikawa H, Shirano M, Kasamatsu Y, et al. Comparative usefulness of inflammatory markers to indicate bacterial infection-analyzed according to blood culture results and related clinical factors. Diagn Microbiol Infect Dis. 2016;84(1):69–73. - PubMed
-
- Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;42(2):580–637. - PubMed
-
- Seki M, Watanabe A, Mikasa K, Kadota J, Kohno S. Revision of the severity rating and classification of hospital-acquired pneumonia in the Japanese Respiratory Society guidelines. Respirology. 2008;13(6):880–885. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials